Ruiling Xie

469 total citations
12 papers, 251 citations indexed

About

Ruiling Xie is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Ruiling Xie has authored 12 papers receiving a total of 251 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cell Biology and 3 papers in Oncology. Recurrent topics in Ruiling Xie's work include Hippo pathway signaling and YAP/TAZ (5 papers), Cancer-related gene regulation (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Ruiling Xie is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (5 papers), Cancer-related gene regulation (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Ruiling Xie collaborates with scholars based in China, United States and Hong Kong. Ruiling Xie's co-authors include Kun‐Liang Guan, Rui Chen, Shenghong Ma, Zhipeng Meng, Zhijie Lin, Mingjie Zhang, Rongxin Wang, Rui You, Ming‐Yuan Chen and You‐Ping Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Cell Biology and Experimental Cell Research.

In The Last Decade

Ruiling Xie

12 papers receiving 249 citations

Peers

Ruiling Xie

MB

CB

ONCOL

EPIDE

IMMUN

Sheng‐An Lee Taiwan

Zhi-Hui Deng China

Samantha S. Dykes United States

Emmanuelle Soleilhac France

Pierre‐Luc Tanguay Canada

Shyam K. More United States

Kexin Zhang China

Betheney R. Pennycook United Kingdom

Qing Duan China

Sami Yokoo Brazil

Sheng‐An Lee Taiwan

Ruiling Xie

271 ×2.0

MB

51 ×0.5

CB

26 ×0.7

ONCOL

17 ×0.6

EPIDE

12 ×0.5

IMMUN

Citations per year, relative to Ruiling Xie Ruiling Xie (= 1×) peers Sheng‐An Lee

Countries citing papers authored by Ruiling Xie

Since Specialization

Citations

This map shows the geographic impact of Ruiling Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruiling Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruiling Xie more than expected).

Fields of papers citing papers by Ruiling Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruiling Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruiling Xie. The network helps show where Ruiling Xie may publish in the future.

Co-authorship network of co-authors of Ruiling Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Ruiling Xie. A scholar is included among the top collaborators of Ruiling Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruiling Xie. Ruiling Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Xie, Ruiling, et al.. (2025). Effect and safety of immunotherapy among elder patients (age ≥ 65) with recurrent or metastatic nasopharyngeal carcinoma. BMC Cancer. 25(1). 691–691. 1 indexed citations

2.

Xie, Ruiling & Yuxin Xu. (2023). Identification of hub genes for glaucoma: a study based on bioinformatics analysis and experimental verification. International Journal of Ophthalmology. 16(7). 1015–1025. 2 indexed citations

3.

Xie, Ruiling, Tianliang Xia, Lan Peng, et al.. (2022). N6-methyladenosine-associated prognostic pseudogenes contribute to predicting immunotherapy benefits and therapeutic agents in head and neck squamous cell carcinoma. Theranostics. 12(17). 7267–7288. 15 indexed citations

4.

Xie, Ruiling, et al.. (2021). The role of the bacterial microbiome in the treatment of cancer. BMC Cancer. 21(1). 934–934. 36 indexed citations

5.

Xie, Ruiling, et al.. (2021). A case report of concurrence of aberrant extracranial internal carotid artery and nonrecurrent laryngeal nerve in a patient of advanced thyroid carcinoma invading hypopharynx. Gland Surgery. 10(5). 1786–1791. 1 indexed citations

6.

Xie, Ruiling, et al.. (2020). The Dysregulation and Prognostic Analysis of STRIPAK Complex Across Cancers. Frontiers in Cell and Developmental Biology. 8. 625–625. 8 indexed citations

7.

Lin, Zhijie, Ruiling Xie, Kun‐Liang Guan, & Mingjie Zhang. (2020). A WW Tandem-Mediated Dimerization Mode of SAV1 Essential for Hippo Signaling. Cell Reports. 32(10). 108118–108118. 17 indexed citations

8.

Zhang, Hui, Chun‐Tao Liu, Jun Mao, et al.. (2020). Development of novel in silico prediction model for drug-induced ototoxicity by using naïve Bayes classifier approach. Toxicology in Vitro. 65. 104812–104812. 25 indexed citations

9.

Xie, Ruiling & Rui Chen. (2020). Mechanisms of Hippo pathway in the pancreatic cancer. SHILAP Revista de lepidopterología. 3(1). 21–28. 2 indexed citations

10.

Chen, Rui, Ruiling Xie, Zhipeng Meng, Shenghong Ma, & Kun‐Liang Guan. (2019). STRIPAK integrates upstream signals to initiate the Hippo kinase cascade. Nature Cell Biology. 21(12). 1565–1577. 93 indexed citations

11.

Lin, Zhijie, Yang Zhou, Ruiling Xie, et al.. (2019). Decoding WW domain tandem-mediated target recognitions in tissue growth and cell polarity. eLife. 8. 32 indexed citations

12.

Wang, Rongxin, et al.. (2018). Circulating regulatory Tfh cells are enriched in patients with chronic hepatitis B infection and induce the differentiation of regulatory B cells. Experimental Cell Research. 365(2). 171–176. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact